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Unexplained recurrent spontaneous abortion (URSA) is an alloimmune disease associated with the failure of fetal-maternal
immunologic tolerance in which the regulatory T lymphocytes (Treg) play a pivotal role. It is well known that Forkhead box
P3 (Foxp3) is a crucial regulatory factor for the development and function of Treg cells. It has also been established that deﬁciency
of the Foxp3 gene suppresses the regulatory function of Treg cells. To determine if functional polymorphisms at the Foxp3 loci
are associated with URSA in humans, we genotyped four common polymorphisms of Foxp3 gene in 146 unrelated URSA patients
and 112 healthy women. The results showed that rs3761548A/C and rs2232365A/G polymorphisms were signiﬁcantly associated
with URSA. Additionally, we found that the allelic distribution of rs5902434 del/ATT in URSA group was slightly diﬀerent from
that in the control group. We conclude that functional polymorphisms of the Foxp3 gene may confer an important susceptibility
to URSA in the Chinese Han population, probably by altering Foxp3 function and/or its expression.
1.Introduction
Recurrent spontaneous abortion (RSA), which is deﬁned as
two or more consecutive pregnancy losses before the 20th
week of gestation from the last menstrual period, occurs
in approximately 1% to 5% of women at reproductive age
[1, 2]. Although many known causes of RSA including
anatomic (15%), infectious (1%–2%), hormonal (20%),
immunological (20%), and genetic (2%–5%) have been
identiﬁed, a signiﬁcant number of cases (approximately
40%–50%) do not have known causes, and these cases are
called unexplained recurrent spontaneous abortion (URSA)
[3]. It has been proposed that URSA belongs to an alloim-
mune disease associated with the failure of fetal-maternal
immunologic tolerance [4, 5]. Treg cells play a critical role
in the induction of a privileged tolerant microenvironment
at the fetal-maternal interface [6].
Growingevidence[7–9]suggeststhatwomenwithURSA
had remarkably reduced frequencies of CD4+CD25+Treg
cellsinperipheralbloodaswellasindeciduas.Thereduction
of Treg cell in URSA patients is closely related to the
decreased expression of Foxp3 [9]. Moreover, a reduced
suppressive capacity of Treg cells has also been implicated
in URSA patients [10]. It is the reduced numbers and/or
functional deﬁciency of CD4+CD25+Treg cells that cause the
predisposition to miscarriage.
Foxp3 is a master regulator gene for the development
a n df u n c t i o no fT r e gc e l l s[ 11]. Deﬁciency of the Foxp3
gene impairs the suppressive function of Treg cells [12].
It has been reported that there are associations between
Foxp3 gene polymorphisms and autoimmune diseases, such
as systemic lupus erythematosus (SLE) [13], autoimmune
thyroid diseases (AITDs) [14], type I diabetes (TID) [15],
and allergic rhinitis [16]. However, the association between2 Clinical and Developmental Immunology
Table 1: Primers used in the genotyping by PCR-SSP or PCR-RFLP.
Marker Allele Forward primer Reverse primer PCR product
Tm/◦C Method Enzyme
rs2232365 A 5 -CCCAGCTCAAG 5 -GGGCTAGTGAG 442bp
PCR-SSP AGACCCCA-3  GAGGCTATTGTAA C-3 
G5  -CCAGCTCAAGA 5 -GCTATTGTAACA 427bp
GACCCCG-3  GTCCTGGCAAGTG-3 
rs5902434 deletion 5 -ACCTTTAAGTCTTCTGCC 5 -TGATTATCAGCG 356bp
PCR-SSP ATTTATTCTATTATTT-3  CACACACTCAT-3 
ATT 5 -CCTTTAAGTCTTCTGCCA 5 -TGATTATCAGCG 358bp
TTTATTCTATTATTA-3  CACACACTCAT-3 
rs3761548 PstI 5 -GCCCTTGTCTA 5 -CAGCCTTCGCCA 487bp
PCR-RFLP CTCCACGCCTCT-3  ATACAGAGCC-3  63◦C
rs2294021 HaeIII 5 -CACACACAATCCAT 5 -ATCTCCATGCCCTA 429bp
PCR-RFLP CCCAGTCACCC-3  AGAAGGCCACC-3  59◦C
Foxp3polymorphismsandURSAhasnotbeendeﬁnedsofar.
Thus,thepurposeofthisstudywastodetermineiffunctional
polymorphisms at the Foxp3 loci were associated with URSA
in humans. We will focus on the following four loci of Foxp3
gene: rs2232365A/G, rs5902434del/ATT, rs3761548A/C, and
rs2294021T/C.
2.MaterialsandMethods
2.1. Subjects. A total of 146 unrelated URSA patients (age:
22–40 years with a median age of 29.1 years) were selected
from the Center of Stem Cell Biology and Tissue Engineer-
ing,SunYat-senUniversity (Guangzhou,China). Allpatients
were treated with immunization using paternal lymphocytes
during the period between January 2009 and October
2010. All patients had histories of at least two successive
miscarriages with unexplained etiology before 12 weeks of
gestation, and there was no successful pregnancy record
(with the same partner) before this treatment. The median
of the number of miscarriages was 3.1. The diagnosis of
“unexplained” abortion was made by the following practical
guidelines [8]: (1) uterus and cervical abnormalities were
excludedbypelvicexamination,ultrasound,andadiagnostic
hysteroscopy; (2) chlamydia and ureaplasma were excluded
by Cervical mucus culturing; (3) chromosome problems
were excluded by Karyotypes of abortion couples and
abortuses; (4) luteal function defect, hyperprolactinemia,
and hyperandrogenemia were excluded by comprehensive
hormonal examinations; (5) endocrine diseases, for exam-
ple, diabetes, hyperthyroidism, and hypothyroidism, were
excluded; (6) autoimmune factors associated with systemic
lupus erythematosus (SLE) and the antiphospholipid syn-
drome (APS) such as antinuclear antibodies (ANA), lupus
anticoagulant (LA), and anticardiolipin antibodies (ACL)
were tested in three consecutive visits every other month;
(7) all male partners had normal semen status. The control
group containing 112 women (age: 23–44 years old) with at
least one live birth was derived from volunteers undergoing
routineannualgynecologicalexaminationinthesamehospi-
tal between 2009 and 2010 and there had been no history of
spontaneous abortion, preterm labor, or preeclampsia. The
subjects in the control group were also examined on the
endocrine and immune factors to exclude individuals with
diabetes, AITDs, SLE and APS. These stringent criterions
described above were used for selection of each subject to
exclude borderline cases and enhance the reliability of the
data. Genomic DNA was extracted from peripheral blood
mononuclear cells using AxyPrep TM blood DNA extraction
Mini Kit (AXYGEN, Pittsburgh, Pa, USA) according to the
manufacturer’s instructions. Written consents of the study
were obtained from all patients and the control population
after the detailed information sessions with each individual.
The study protocol was approved by the Ethics Committee of
Sun Yat-Sen University.
2.2. Genotyping of rs2232365A/G and rs5902434del/ATT Poly-
morphisms. Genotypes of rs2232365A/G and rs5902434/
ATTweredeterminedbyusingthepolymerasechainreaction
(PCR) with sequence-speciﬁc primers (PCR-SSP, Table 1).
PCR was performed in a volume of 30μL, containing 1μL
(20ng) of genomic DNA, 2μL (10pmol) of each primer,
15μL of Takara Ex Tap Mix and 10μL of ddH2O. A “touch
down” procedure was applied after an initial preheating step
for 1min at 98◦C. The PCR parameter for ampliﬁcation of
rs2232365 locus was as follows (the annealing temperatures
for rs5902434 was 62◦C, 57◦C, and 51◦C, resp.).
The ampliﬁed PCR products were analyzed using 1.5%
agarose gel electrophoresis, stained with ethidium bromide
and photographed.
2.3. Genotyping of rs3761548A/C and rs2294021T/C Poly-
morphisms. Genotypes of rs3761548A/C and rs2294021T/C
were determined using PCR-restriction fragment length
polymorphism (PCR-RFLP, Table 1) method. PCR was per-
formed in a volume of 30μL, with 1μL (20ng) of genomic
DNA, 2μL (10pmol) of each primer, 15μL of Takara Ex Tap
Mix and 10μL of ddH2O, The parameters for PCR includeClinical and Developmental Immunology 3
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Figure 1: Typical band patterns of PCR-SSP or PCR-RFLP products. (a) is the band pattern for rs2232365. Lane 1 and 3 indicated A/G
genotype; Lane 2 indicated A/A genotype; Lane 4 indicated G/G genotype. (b) is the band pattern for rs5902434. Lane 1, 2, and 3 indicated
ATT/ATT genotype; Lane 4, 5, and 6 indicated del/ATT genotype; Lane 7 indicated del/del genotype. (c) is the band pattern for rs3761548.
Lane 1 indicated A/A genotype; Lane 2 indicated C/C genotype; Lane 3, 4, and 5 indicated A/C genotype. (d) is the band pattern for
rs2294021. Lane 1, 2 indicated T/C genotype; Lane 3, 4, and 6 indicated C/C genotype; Lane 5, 7 indicated T/T genotype. M represented
100bp DNA marker.
an initial denaturing step at 98◦C for 1min, followed by 35
cycles of 98◦C for 30sec, annealing for 30sec, and extension
at 72◦C for 1min, and a ﬁnal extension at 72◦C for 7min.
A1 5μL aliquot was digested with 1μLr e s t r i c t i o ne n z y m ea t
37◦C for 16 hours and then separated on a 2% agarose gel.
To ensure that the results were repeatable, a 10% sample of
the subjects in the patient group and the control group were
genotyped twice and the reproducibility was 100%.
2.4. Statistical Analysis. Hardy-Weinberg equilibrium
(HWE) test, linkage disequilibrium test, and haplotype
frequencies for pairs of alleles were estimated using software
HAPLOVIEW (version 4.2). The genotype, allele frequency
in URSA patients and control group were analyzed by
standard Chi-square test. Unconditional univariate and
binary logistic regression analyses were performed to obtain
the odds ratio (OR) for risk of URSA at 95% conﬁdence
intervals (CI). All statistical analysis were performed using
the SPSS 13.0 software package (SPSS, Chicago, I/l, USA).
3. Results
3.1. Identiﬁcation of Genotypes of the Foxp3 Polymorphisms.
For genotyping of rs2232365A/G and rs5902434del/ATT,
each DNA sample was tested in duplicates with one reaction4 Clinical and Developmental Immunology
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Figure 2: Schematic structure of the human Foxp3 gene and the linkage disequilibrium as determined in the URSA population (Haploview
4.20 version). The coding sequences, noncoding sequences and the introns were depicted as black boxes, white boxes, and horizontal lines,
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rs5902434 (1), rs3761548 (2), rs2232365 (3), rs2294021 (4), (GT)n microsatellite polymorphisms, the start cordon, and the stop cordon
were indicated by arrows. The standard (D/LOD) was represented by red color and r 2 was presented as a number if it deviates from 100.
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per allele of each locus. The A/A, A/G, and G/G genotypes
had one (442bp), two (442bp and 427bp), and one
(427bp) band(s), respectively. The del/del, del/ATT, and
ATT/ATT genotypes also had one (358bp), two (358bp and
356bp), one (356bp) band(s), respectively. Genotypes of
rs3761548A/C were deﬁned by the presence of three diﬀerent
bands: A/A (487bp), A/C (487bp, 329bp and 158bp),
and C/C (329bp, 158bp). For rs2294021T/C, genotypes
were deﬁned by the presence of ﬁve distinct patterns of
bands: T/T (322bp, 87bp, and 20bp), T/C (422bp, 216bp,
106bp, 87bp, and 20bp), C/C (216bp, 106bp, 87bp, and
20bp). The 20bp band was running out of the gel. The
representativegelsshowingthetypicalpatternsofbandswere
presented in Figure 1.
3.2. Genotypic and Allelic Distribution of the Foxp3 Polymor-
phisms in the Subjects of URSA and Control Groups. All the
four SNPs were in HWE for both URSA group and control
group with a P value from 0.08 to 0.85. In addition, these
4 SNPs were under linkage disequilibrium in the URSA
group (Figure 2). The genotypic and allelic frequencies data
were shown in Table 2. We performed statistical analysis to
determine the association between each of the SNPs and
URSA. There was no statistical diﬀerence between the geno-
typic and allelic frequencies of rs2294021T/C polymorphism
in the URSA group and those in the control group. The
genotypic frequencies of rs5902434 del/ATT polymorphism
did not diﬀer signiﬁcantly between the URSA and control
groups, but a weak association was observed in the allelic
distribution (P = 0.036) between URSA and control groups.
The genotypic and allelic distributions of rs2232365 A/G
and rs3761548A/C were statistically diﬀerent between the
URSA and control groups. Consistent with the rs2232365 G
allelic distribution, the frequency of the combined genotypes
(A/G + G/G) in the URSA group (94.5%) was signiﬁcantly
higher than that in the control group (84.82%) (P = 0.009).
The risk of URSA in women with G allele was higher than
that in women with A allele (OR = 1.61, 95% CI = (1.11,
2.32)). Similar to the locus of rs2232365, the distribution
of genotypes and alleles at the locus rs3761548 was also
signiﬁcantly diﬀerent between the URSA and control groups.
3.3. Analysis of Haplotypes Based on the Three Polymorphisms
in the Promoter Region. Because haplotypes are clusters of
genetic variants and are inherited as a unit on the same
chromosome, we stratiﬁed the subjects in URSA group and
control group based on the Foxp3 promoter region haplo-
types to explore the relative inﬂuence of each individual hap-
lotype on URSA susceptibility. Of the 8 haplotypes (Table 3)
deﬁned by three polymorphisms at positions rs5902434,
rs3761548, and rs2232365, they were classiﬁed into four
distinct groups: ATT-C-A, ATT-A-A, del-A-G and del-C-G.Clinical and Developmental Immunology 5
Table 2: Genotype and allele frequencies of the four Foxp3 polymorphisms in controls and URSA patients together with case-control
analysis.
Marker Genotype allele URSA N (%) Controls N (%) χ2 value P value OR (95% CI)
rs2294021 C/C 65 (44.50) 40 (35.70)
T/C 70 (47.90) 57 (50.90)
T/T 11 (7.60) 15 (13.40) 3.480 0.18a
C/C 65 (44.50) 40 (35.70)
T/C + T/T 81 (55.50) 72 (64.30) 2.037 0.154b
T/C 70 (47.90) 57 (50.09)
C/C + T/T 76 (52.10) 55 (49.10) 0.220 0.639b
T/T 11 (7.60) 15 (13.40)
C/C + T/C 135 (92.40) 97 (86.60) 2.401 0.121b
rs5902434 ATT/ATT 11 (7.53) 14 (12.50)
del/ATT 62 (42.47) 56 (50.00)
del/del 73 (50.0) 42 (37.50) 4.620 0.10a
ATT/ATT 11 (7.53) 14 (12.50)
del/ATT + del/del 135 (92.47) 98 (87.50) 1.786 0.181b
del/ATT 62 (42.47) 56 (50.00)
del/del + ATT/ATT 84 (57.53) 56 (50.00) 1.450 0.229b
del/del 73 (50.0) 42 (37.50)
del/ATT + ATT/ATT 73 (50.00) 70 (62.50) 4.008 0.045b 0.60 (0.36, 0.99)
rs2232365 A/A 8 (5.48) 17 (15.18) 8.320 0.016a 1
A/G 70 (47.94) 56 (50.00) 4.640 0.031b 2.66 (1.07, 6.61)
G/G 68 (46.58) 39 (34.82) 8.260 0.004b 3.71 (1.47, 9.37)
A/G 70 (47.94) 56 (50.00)
A/A + G/G 76 (52.06) 56 (50.00) 0.107 0.743b
G/G 68 (46.58) 39 (34.82)
A/A + A/G 78 (53.42) 73 (65.18) 3.607 0.058b
A/A 8 (5.48) 17 (15.18)
A/G + G/G 138 (94.52) 95 (84.82) 6.810 0.009b 3.09 (1.28, 7.44)
rs3761548 C/C 15 (10.27) 25 (22.32) 8.280 0.016a 1
A/C 56 (38.36) 45 (40.18) 1.690 0.193b 1.44 (0.83, 2.47)
A/A 75 (51.37) 42 (37.50) 8.620 0.003b 2.98 (1.42, 6.26)
A/C 56 (38.36) 45 (40.18)
C/C + A/A 90 (61.64) 67 (59.82) 0.088 0.076a
A/A 75 (51.37) 42 (37.50)
C/C + A/C 71 (48.63) 70 (62.50) 4.920 0.027b 0.57 (0.34, 0.94)
C/C 15 (10.27) 25 (22.32)
A/C + A/A 131 (89.73) 87 (77.68) 7.020 0.008b 2.51 (1.25, 5.03)
rs2294021 C 200 (68.50) 137 (61.20)
T 92 (31.50) 87 (38.80) 3.01 0.080c 1.38 (0.96, 1.99)
rs5902434 ATT 84 (28.77) 84 (37.50)
del 208 (71.23) 140 (62.50) 4.40 0.036c 1.49 (1.03, 2.15)
rs2232365 A 86 (29.45) 90 (40.18)
G 206 (70.55) 134 (59.82) 6.50 0.010c 1.61 (1.11, 2.32)
rs3761548 C 86 (29.45) 95 (42.40)
A 206 (70.55) 129 (57.60) 8.37 0.003c 1.73 (1.20, 2.50)
Pa was determined by Pearson’s Chi-square test for 3 ×2 contingency tables.
Pb, Pc was determined by Pearson’s Chi-square test for 2 ×2 contingency tables.
Pa 0.05, Pb 0.017, Pc 0.05 are considered statistically signiﬁcant.6 Clinical and Developmental Immunology
Table 3: Eight three-locus Foxp3 promoter region haplotypes identiﬁed in URSA group and the control group and their estimated
frequencies using the software HAPLOVIEW (version 4.2).
Allele Haplotype frequency (N,% )
rs5902434 rs3761548 rs2232365 URSA Control χ2 value P OR (95% CI)
del C A 6 (2.1) 8 (3.4) 0.824 0.36
del A G 187 (64.1) 93 (41.6) 25.86 0.000 2.51 (1.75.3.58)
del C G 9 ( 3.2) 35 (15.8) 25.39 0.000 0.18 (0.08, 0.37)
del A A 5 (1.8) 4 (1.7) 0.013 0.91
ATT A G 4 (1.3) 2 (0.7) 0.387 0.53
ATT A A 10 (3.3) 30 (13.5) 18.6 0.000 0.22 (0.10, 0.46)
ATT C G 6 (1.9) 4 (1.6) 0.05 0.82
ATT C A 65 (22.3) 48 (21.6) 0.033 0.86
The frequencies of the latter 3 haplotypes (ATT-A-A, del-A-
G, and del-C-G) were signiﬁcantly diﬀerent between URSA
and control groups. The proportion of haplotype ATT-A-A
and Del-C-G in URSA group was signiﬁcantly lower than
that in the control group, indicating that these haplotypes
play a protective role in the occurrence of URSA, In contrast,
haplotype del-A-G is a risk factor of URSA (OR = 2.51.95%
CI = (1.75, 3.58)).
4. Discussion
Treg cells play a central role in the induction and main-
tenance of fetal-maternal immunologic tolerance. Devel-
opment of Treg cells requires continued expression of
Foxp3 [17], while attenuated Foxp3 expression results in its
functional deﬁciency [18], We hypothesized that functional
polymorphisms of the Foxp3 gene may contribute to the
pathogenesis of URSA.
In the cases of the rs3761548A/C polymorphism, the A
allele was a risk factor for SLE [13], AITDs [14], allergic
rhinitis [16]. Interestingly, we found that genotypic fre-
quency of rs3761548AA was signiﬁcantly diﬀerent between
the URSA group and control group. Previous studies have
shown that individuals with a genotype of rs3761548AA
have the lowest production of Foxp3 among the three
genotypes of this polymorphism [19]. Therefore, URSA
patients with the AA genotype may have fewer Treg cells
and/or weaker suppressive function and are diﬃcult to
achieve fetal tolerance, these results are consistent with
previous reports, showing a decrease in the proportion of
F o x p 3 +T r e gc e l l si nU R S Ap a t i e n t s[ 8, 9]. Taken together,
our results suggested that the rs3761548AA genotype may
contribute to the occurrence of URSA.
Forthepolymorphismofrs2232365A/G,thedistribution
of alleles and genotypes diﬀer signiﬁcantly between the
URSA group and control group. The risk of URSA in the
women with G allele was higher than that in the women
carrying an A allele (OR = 1.61, 95% CI = (1.11, 2.32)).
These results are also consistent with the previous work
[15], showing that Type I diabetes (TID) carrying a G
allele has a higher occurrence of beta-cell failure. Because
the functional diﬀerences between diﬀerent genotypes are
still unclear, we performed an extensive search for tran-
scriptional factor-binding sites using TF-Search online tool
( http://www.cbrc.jp/research/db/TFSEARCH.html). Inter-
estingly,SNPvariantofrs2232365A/Gislocatedinaputative
bindingsiteforthetranscriptionfactorGATA-3,knowntobe
essential for the Th2 immune response. More importantly,
only when the A allele exists, can GATA-3 bind the promoter
region of Foxp3. Th1/Th2 cytokine balance with Th2 pre-
dominance is a very important mechanism for the survival
of the fetus in the maternal uterus [20]. It is also shown
that Treg cells modulate the Th1/Th2 cell balance toward
Th2 cell, and thus upregulate Th2 immune response [21].
Every recently, an intrinsic mechanism predisposing Foxp3-
expressing regulatory T cells to Th2 conversion through
GATA-3 in vivo has been identiﬁed [22]. Hence, we inferred
that high frequencies of G allele and G/G genotype in URSA
patients might decrease Th2 immune response and disrupt
the balance of Th1/Th2, leading to a detrimental eﬀect on
the fetus during pregnancy.
The human Foxp3 gene is located in the small arm of
the X-chromosome. Random inactivation of X-chromosome
results in the presence of only two phenotypes for each poly-
morphism [23], because the phenotype of the heterozygous
genotype is identical to that of a homozygous genotype.
Therefore, we performed stratiﬁcation analysis based on the
possible phenotypes. Stratiﬁcation of the URSA patients and
controls by heterozygotes and homozygotes failed to detect
any evidence that the heterozygotes were more frequent in
URSA group, which was in contrast to the results from
the previous studies [14, 16]. Among the 4 SNPs, however,
the combinational genotypes del/del + del/ATT, A/G +
G/G, C/C + A/C, and A/G + G/G appeared signiﬁcantly
diﬀerent between the URSA and control groups, whereas
only A/G + G/G and C/C + A/C were still signiﬁcant after the
Bonferroni correction for multiple testing of three tests(P 
0.017).These data, combined with the results from the hap-
lotype analysis further provided evidence for the association
between Foxp3 gene and URSA and supported that immune
dysregulation is secondary to promoter heterogeneity in the
Foxp3 gene. While some correlation has been found in the
study, it is still very important to examine a larger number
of samples from diﬀerent populations and to investigate
the proportions of Treg cells and Foxp3 expression or evenClinical and Developmental Immunology 7
their suppressive capacity in peripheral or decidua among
diﬀerent genotypes in URSA patients to obtain more reliable
conclusions.
5. Conclusions
We have evaluated the role of Foxp3 gene functional
polymorphisms in the pathogenesis of URSA. Two func-
tional polymorphisms in Foxp3 gene (rs2232365A/G and
rs3761548A/C) are related to the occurrence of URSA. These
results highlight the important role of Foxp3 in successful
pregnancy.
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